FDA advisory panel votes to recommend Johnson & Johnson vaccine Emergency Use Authorization
The Food and Drug Administration advisory panel unanimously voted Friday afternoon to recommend the Johnson & Johnson’s COVID-19 vaccine for an emergency use authorization. For eight hours, the group of independent experts had reviewed the safety and efficacy of the vaccine. READ: FDA finds Johnson & Johnson vaccine effectively prevents COVIDWhile the Johnson & Johnson vaccine is less effective than Pfizer and Moderna’s vaccines, the experts noted that no one who received the Johnson & Johnson vaccine was hospitalized or died from coronavirus. READ: Here’s what makes J&J vaccine different than the othersAdStudies in children are planned with the older group of children expected to begin receiving the vaccine as soon as early March. There are also additional studies planned in immunocompromised people.
University of Michigan seeks volunteers for COVID-19 vaccine testing
ANN ARBOR, Mich. Metro Detroit is now the site of four COVID-19 vaccine trials. The latest is being conducted at the University of Michigan and involves a vaccine developed by Oxford University and pharmaceutical company AstraZeneca. Sept. 2, 2020: Michigan coronavirus (COVID-19) cases up to 103,710; Death toll now at 6,509The university said 30,000 volunteers will be needed to test the vaccine. We definitely want to have people participate who reflect the people in the community who are getting COVID and are getting sick with COVID, Kaul said. For more information, or to volunteer for the vaccine trial, click here.
University of Michigan to carry out phase 3 of COVID-19 vaccine trial
U-Ms academic medical center, Michigan Medicine, is working with AstraZeneca to carry out the third trial phase of a potential vaccine for COVID-19. The University of Michigan is one of multiple U.S. sites testing the investigational vaccine against COVID-19. Officials say the phase three clinical trial is expected to include about 30,000 participants in total over the course of two years. We are proud to advance the University of Michigans outstanding legacy of excellence in vaccine trials with this important clinical trial partnership, said Mark Schlissel, M.D., Ph.D., president of the University of Michigan. For more information, or to volunteer for the vaccine trial, click here.
Michigan volunteers receive first shot in Moderna COVID-19 vaccine study
DETROIT The first group of volunteers in Michigan to participate in the Moderna COVID-19 vaccine study received their first shots Wednesday, Henry Ford Health System announced. Henry Ford Health System is the only hospital in Michigan selected as a trial site for phase three of the Moderna mRNA-1273 Coronavirus Efficacy (COVE) vaccine study. This is a historic moment, said Dr. Marcus Zervos, division chief of Infectious Disease for Henry Ford Health System. I give them all the respect in the world.The first dose of the Moderna COVID-19 vaccine study in Michigan was administered Wednesday, Aug. 5, 2020. About 90 healthcare systems across the United States are working competitively to enroll a total of 30,000 volunteers to participate in the Moderna vaccine study.
Henry Ford brings fight to find COVID-19 vaccine to Michigan
DETROIT On Tuesday, Henry Ford Health System announced it is bringing the fight to find a coronavirus (COVID-19) vaccine to Michigan. Henry Ford has been selected as one of the 89 testing sites nationwide for the Moderna Vaccine. Henry Ford is the only site in Michigan. Henry Ford hopes to enroll a diverse group of volunteers. READ MORE: Henry Ford Health System seeks volunteers for Moderna COVID-19 vaccine study